Transparency

Market Access

Securing the future: Innovating pharmaceutical supply chain ...

Supply chain disruptions are taking centre stage in the media landscape at the outset of 2024, with incidents ranging from blockages in the Panama and Suez Canals to escalating geopolitical

Market Access

How transparent is the VPAG?

Leela Barham takes a look at the transparency of the UK’s new pricing and access scheme, the 2024 VPAG, based on public sources.

Market Access

Supply chains and the importance of transparency

The pandemic revealed that global supply chains for the pharma industry are more fragile than expected.

Patients

Patient involvement at NICE: In whose interest is it anyway?

The National Institute for Health and Care Excellence (NICE) released a new

News

Study shows there is still a long way to go on trial diversi...

It's no revelation that the pharma industry has often fallen short when it comes to making sure its clinical trial populations include representation of racial and ethnic minorities, but a

News

Achievement-so-far-on-objective-on-affordability

Pharma says VPAS clawback jeopardises UK sector

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening "footprint, R&D, and manufacturing investments" in the country.

Securing the future: Innovating pharmaceutical supply chain ...

How transparent is the VPAG?

Supply chains and the importance of transparency

Patient involvement at NICE: In whose interest is it anyway?

Study shows there is still a long way to go on trial diversi...

Pharma says VPAS clawback jeopardises UK sector

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Transparency

Editor's Picks